| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 05 Nov 2026 | S-3ASR |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
HAMPTON, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial results for the third quarter ended September 30, 2026 and provided a corporate update. |
| 07 Oct 2026 | SCHEDULE 13G/A |
| 22 Sep 2026 |
8-K: Other Events
Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints |
| 14 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
HAMPTON, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial results for the second quarter ended June 30, 2026 and provided a corporate update. |
| 15 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On July 10, 2026, Sam Martin, Senior Vice President and Chief Financial Officer of Celldex Therapeutics, Inc. (the “Company”), notified the Company of his plans to retire effective on or about March 31, 2027. Mr. Martin joined the Compan... |
| 29 Jun 2026 |
Form 4: Lawver Teri L, SVP & Chief Commercial Officer
Granted 90,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Jimenez Freddy A., SVP & GENERAL COUNSEL
Granted 93,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Young Diane C., SVP, CHIEF MEDICAL OFFICER
Granted 57,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Heath-Chiozzi Margo, SVP OF REGULATORY AFFAIRS
Granted 95,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Martin Samuel Bates, SVP AND CFO
Granted 93,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Cavanaugh Sarah, SVP OF CORP AFFAIRS & ADMIN.
Granted 95,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Crowley Elizabeth, SR. VP & CPDO
Granted 100,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Pepin Ronald, SR. VP & CBO
Granted 20,000 Incentive Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Keler Tibor, EXECUTIVE VP & CSO
Granted 115,000 Incentive Stock Option (right to buy) |
Loading...